Prelude Capital Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Prelude Capital Management's NVAX Position: Q2 2026 in Review
Prelude Capital Management opened a new position in Novavax (NVAX) in Q2 2026: 20,300 shares worth $191K. The stake represents 0.01% of the portfolio and ranks #997 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in NVAX as recently as Q1 2025.
Prelude Capital Management first reported a position in NVAX in Q3 2015 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Prelude Capital Management held 20,300 shares of Novavax worth $191K as of Q2 2026.
- Novavax was a new Prelude Capital Management position in Q2 2026.
- Novavax made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #997 holding.
- Prelude Capital Management first reported a position in Novavax in Q3 2015 and has held it in 4 quarters since.
- 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.